Molecular mechanism and pharmacokinetics of flavonoids in the treatment of resistant EGF receptor‐mutated non‐small‐cell lung cancer: A narrative review-Reference-Cited by-同舟云学术

Molecular mechanism and pharmacokinetics of flavonoids in the treatment of resistant EGF receptor‐mutated non‐small‐cell lung cancer: A narrative review

Published:2021-02-12 Issue:6 Volume:178 Page:1388-1406
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Wang Xuewen¹,Chen Bing¹²³,Xu Dafen¹,Li Zhijun⁴,Liu Hao⁴,Huang Zhengjun¹²³,Huang Kangping⁴,Lin Xinhua¹²³^ORCID,Yao Hong¹²³

Affiliation:

1. Department of Pharmaceutical Analysis, School of Pharmacy Fujian Medical University Fuzhou Fujian China

2. Nano Medical Technology Research Institute Fujian Medical University Fuzhou Fujian China

3. Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province Fujian Medical University Fuzhou Fujian China

4. School of Pharmacy Fujian Medical University Fuzhou Fujian China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15360

Reference162 articles.

1. Genistein, a specific inhibitor of tyrosine-specific protein kinases.

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

3. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors

4. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors

5. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of catechin on the malignant biological behavior of gastric cancer cells through the PI3K/Akt signaling pathway;Toxicology and Applied Pharmacology;2024-09

2. Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis;Phytotherapy Research;2023-08-24

3. Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics;Nutrients;2023-04-26

4. Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice;Frontiers in Pharmacology;2023-04-07

5. Identification of a novel nitroflavone-based scaffold for designing mutant-selective EGFR tyrosine kinase inhibitors targeting T790M and C797S resistance in advanced NSCLC;Bioorganic Chemistry;2022-12